Influence of Polymerase II Processivity on Alternative Splicing Depends on Splice Site Strength

Transcription and pre-mRNA splicing are coordinated temporally and spatially, and both processes can influence each other. In particular, control of transcriptional elongation by RNA polymerase II has proved to be important for alternative splicing regulation. In this report we demonstrate that the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nogués, G., Muñoz, M.J., Kornblihtt, A.R.
Formato: JOUR
Materias:
RNA
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_00219258_v278_n52_p52166_Nogues
Aporte de:
id todo:paper_00219258_v278_n52_p52166_Nogues
record_format dspace
spelling todo:paper_00219258_v278_n52_p52166_Nogues2023-10-03T14:23:04Z Influence of Polymerase II Processivity on Alternative Splicing Depends on Splice Site Strength Nogués, G. Muñoz, M.J. Kornblihtt, A.R. Cell culture Enzyme inhibition Genes Mutagenesis RNA Splice site strength Enzymes elongation factor fibronectin fibronectin extra domain I messenger RNA polypyrimidine tract binding protein RNA polymerase II unclassified drug article controlled study enzyme activation enzyme inhibition exon gene mutation human human cell molecular recognition nonhuman point mutation priority journal regulatory mechanism RNA splicing silencer element transcription regulation Alternative Splicing Binding Sites Cell Line Cell Line, Tumor Exons Herpes Simplex Virus Protein Vmw65 Humans Models, Biological Mutation Phosphorylation Plasmids Point Mutation Polymorphism, Genetic Protein Structure, Tertiary Pyrimidines RNA Polymerase II RNA Splicing RNA, Messenger Time Factors Transcription, Genetic Transfection Transcription and pre-mRNA splicing are coordinated temporally and spatially, and both processes can influence each other. In particular, control of transcriptional elongation by RNA polymerase II has proved to be important for alternative splicing regulation. In this report we demonstrate that the efficiency of exon recognition by the splicing machinery is crucial for the elongation control. Alternative splicing of the fibronectin extra domain I (EDI) is because the polypyrimidine tract of its 3'-splice site occurs suboptimal. By mutating the polypyrimidine tract of EDI in two different positions, individually or in combination, and by disrupting its exonic splicing silencer, we managed to generate minigenes with increasing degrees of exon recognition. Improvement of exon recognition is evidenced by independence from the splicing regulator SF2/ASF for inclusion. The mutated minigenes were used to transfect human cells in culture and study the responsiveness of EDI alternative splicing to activation or inhibition of pol II elongation. Our results revealed that responsiveness of exon skipping to elongation is inversely proportional to 3'-splice site strength, which means that the better the alternative exon is recognized by the splicing machinery, the less its degree of inclusion is affected by transcriptional elongation. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_00219258_v278_n52_p52166_Nogues
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Cell culture
Enzyme inhibition
Genes
Mutagenesis
RNA
Splice site strength
Enzymes
elongation factor
fibronectin
fibronectin extra domain I
messenger RNA
polypyrimidine tract binding protein
RNA polymerase II
unclassified drug
article
controlled study
enzyme activation
enzyme inhibition
exon
gene mutation
human
human cell
molecular recognition
nonhuman
point mutation
priority journal
regulatory mechanism
RNA splicing
silencer element
transcription regulation
Alternative Splicing
Binding Sites
Cell Line
Cell Line, Tumor
Exons
Herpes Simplex Virus Protein Vmw65
Humans
Models, Biological
Mutation
Phosphorylation
Plasmids
Point Mutation
Polymorphism, Genetic
Protein Structure, Tertiary
Pyrimidines
RNA Polymerase II
RNA Splicing
RNA, Messenger
Time Factors
Transcription, Genetic
Transfection
spellingShingle Cell culture
Enzyme inhibition
Genes
Mutagenesis
RNA
Splice site strength
Enzymes
elongation factor
fibronectin
fibronectin extra domain I
messenger RNA
polypyrimidine tract binding protein
RNA polymerase II
unclassified drug
article
controlled study
enzyme activation
enzyme inhibition
exon
gene mutation
human
human cell
molecular recognition
nonhuman
point mutation
priority journal
regulatory mechanism
RNA splicing
silencer element
transcription regulation
Alternative Splicing
Binding Sites
Cell Line
Cell Line, Tumor
Exons
Herpes Simplex Virus Protein Vmw65
Humans
Models, Biological
Mutation
Phosphorylation
Plasmids
Point Mutation
Polymorphism, Genetic
Protein Structure, Tertiary
Pyrimidines
RNA Polymerase II
RNA Splicing
RNA, Messenger
Time Factors
Transcription, Genetic
Transfection
Nogués, G.
Muñoz, M.J.
Kornblihtt, A.R.
Influence of Polymerase II Processivity on Alternative Splicing Depends on Splice Site Strength
topic_facet Cell culture
Enzyme inhibition
Genes
Mutagenesis
RNA
Splice site strength
Enzymes
elongation factor
fibronectin
fibronectin extra domain I
messenger RNA
polypyrimidine tract binding protein
RNA polymerase II
unclassified drug
article
controlled study
enzyme activation
enzyme inhibition
exon
gene mutation
human
human cell
molecular recognition
nonhuman
point mutation
priority journal
regulatory mechanism
RNA splicing
silencer element
transcription regulation
Alternative Splicing
Binding Sites
Cell Line
Cell Line, Tumor
Exons
Herpes Simplex Virus Protein Vmw65
Humans
Models, Biological
Mutation
Phosphorylation
Plasmids
Point Mutation
Polymorphism, Genetic
Protein Structure, Tertiary
Pyrimidines
RNA Polymerase II
RNA Splicing
RNA, Messenger
Time Factors
Transcription, Genetic
Transfection
description Transcription and pre-mRNA splicing are coordinated temporally and spatially, and both processes can influence each other. In particular, control of transcriptional elongation by RNA polymerase II has proved to be important for alternative splicing regulation. In this report we demonstrate that the efficiency of exon recognition by the splicing machinery is crucial for the elongation control. Alternative splicing of the fibronectin extra domain I (EDI) is because the polypyrimidine tract of its 3'-splice site occurs suboptimal. By mutating the polypyrimidine tract of EDI in two different positions, individually or in combination, and by disrupting its exonic splicing silencer, we managed to generate minigenes with increasing degrees of exon recognition. Improvement of exon recognition is evidenced by independence from the splicing regulator SF2/ASF for inclusion. The mutated minigenes were used to transfect human cells in culture and study the responsiveness of EDI alternative splicing to activation or inhibition of pol II elongation. Our results revealed that responsiveness of exon skipping to elongation is inversely proportional to 3'-splice site strength, which means that the better the alternative exon is recognized by the splicing machinery, the less its degree of inclusion is affected by transcriptional elongation.
format JOUR
author Nogués, G.
Muñoz, M.J.
Kornblihtt, A.R.
author_facet Nogués, G.
Muñoz, M.J.
Kornblihtt, A.R.
author_sort Nogués, G.
title Influence of Polymerase II Processivity on Alternative Splicing Depends on Splice Site Strength
title_short Influence of Polymerase II Processivity on Alternative Splicing Depends on Splice Site Strength
title_full Influence of Polymerase II Processivity on Alternative Splicing Depends on Splice Site Strength
title_fullStr Influence of Polymerase II Processivity on Alternative Splicing Depends on Splice Site Strength
title_full_unstemmed Influence of Polymerase II Processivity on Alternative Splicing Depends on Splice Site Strength
title_sort influence of polymerase ii processivity on alternative splicing depends on splice site strength
url http://hdl.handle.net/20.500.12110/paper_00219258_v278_n52_p52166_Nogues
work_keys_str_mv AT noguesg influenceofpolymeraseiiprocessivityonalternativesplicingdependsonsplicesitestrength
AT munozmj influenceofpolymeraseiiprocessivityonalternativesplicingdependsonsplicesitestrength
AT kornblihttar influenceofpolymeraseiiprocessivityonalternativesplicingdependsonsplicesitestrength
_version_ 1782028803488350208